May 15, 2007; 68 (20) Articles
Phenotype of Charcot–Marie–Tooth disease Type 2
H.M.E. Bienfait, F. Baas, J. H.T.M. Koelman, R. J. de Haan, B. G.M. van Engelen, A. A.W.M. Gabreëls-Festen, B. W. Ongerboer de Visser, F. Meggouh, M. A.J. Weterman, P. De Jonghe, V. Timmerman, M. de Visser
First published May 14, 2007, DOI: https://doi.org/10.1212/01.wnl.0000263479.97552.94
H.M.E. Bienfait
F. Baas
J. H.T.M. Koelman
R. J. de Haan
B. G.M. van Engelen
A. A.W.M. Gabreëls-Festen
B. W. Ongerboer de Visser
F. Meggouh
M. A.J. Weterman
P. De Jonghe
V. Timmerman
Phenotype of Charcot–Marie–Tooth disease Type 2
H.M.E. Bienfait, F. Baas, J. H.T.M. Koelman, R. J. de Haan, B. G.M. van Engelen, A. A.W.M. Gabreëls-Festen, B. W. Ongerboer de Visser, F. Meggouh, M. A.J. Weterman, P. De Jonghe, V. Timmerman, M. de Visser
Neurology May 2007, 68 (20) 1658-1667; DOI: 10.1212/01.wnl.0000263479.97552.94
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 68 no. 20 1658-1667
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published May 14, 2007.
Copyright & Usage:
© 2007
Author Disclosures
- H.M.E. Bienfait, MD,
- F. Baas, MD, PhD,
- J. H.T.M. Koelman, MD, PhD,
- R. J. de Haan, PhD,
- B. G.M. van Engelen, MD, PhD,
- A. A.W.M. Gabreëls-Festen, MD, PhD,
- B. W. Ongerboer de Visser, MD, PhD,
- F. Meggouh, PhD,
- M. A.J. Weterman, PhD,
- P. De Jonghe, MD, PhD,
- V. Timmerman, PhD and
- M. de Visser, MD, PhD
- H.M.E. Bienfait, MD,
- F. Baas, MD, PhD,
- J. H.T.M. Koelman, MD, PhD,
- R. J. de Haan, PhD,
- B. G.M. van Engelen, MD, PhD,
- A. A.W.M. Gabreëls-Festen, MD, PhD,
- B. W. Ongerboer de Visser, MD, PhD,
- F. Meggouh, PhD,
- M. A.J. Weterman, PhD,
- P. De Jonghe, MD, PhD,
- V. Timmerman, PhD and
- M. de Visser, MD, PhD
- From the Department of Neurology (H.M.E.B. M.d.V.), Unit of Clinical Neurophysiology (J.H.T.M.K., B.W.O.d.V.), Neurogenetics Laboratory (F.B., F.M., M.A.J.W.), and Department of Clinical Epidemiology and Biostatistics (R.J.d.H.), Academic Medical Center, University of Amsterdam, The Netherlands; Institute of Neurology, University Medical Center St. Radboud, Nijmegen, The Netherlands (A.A.W.M.G.-F., B.G.M.v.E.); and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, University of Antwerp, Antwerpen, Belgium (P.D.J., V.T.).
- Address correspondence and reprint requests to Dr. M. de Visser, Department of Neurology, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, The Netherlands M.deVisser{at}amc.uva.nl.
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement